Rakesh Parmar

Title: Rakesh Parmar: Innovator in Pharmaceutical Compounds

Introduction

Rakesh Parmar is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit the CFTR channel. With a total of 2 patents to his name, Parmar's work is recognized for its therapeutic potential.

Latest Patents

Parmar's latest patents include innovative compounds aimed at addressing critical health issues. The first patent focuses on tricyclic compounds for inhibiting the CFTR channel. This invention provides a compound of formula I or a pharmaceutically acceptable salt thereof, along with its therapeutic uses. Additionally, it offers a combination of pharmacologically active agents and a pharmaceutical composition. The second patent involves substituted pyrazino[1',2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines, and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel. Similar to the first, this invention also provides a compound of formula I or a pharmaceutically acceptable salt thereof, along with its therapeutic uses and a combination of pharmacologically active agents.

Career Highlights

Rakesh Parmar is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing therapeutic options for patients.

Collaborations

Parmar has collaborated with notable colleagues, including Mahbub Ahmed and Alexander Ashall-Kelly. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Rakesh Parmar is a distinguished inventor whose work in pharmaceutical compounds has the potential to make a significant impact on healthcare. His patents reflect a commitment to innovation and therapeutic advancement.